Publications

Academic contributions to cancer biology.

Most Recent Publications (selected)

  • Liu X, He L, Zhao M, Golomb SM, Ma W, Yang X, Aleksandrovic E, Borges HM, Dean KM, Wang L, Hon GC, Gan D, Zhu H, Li J, Xu L, Zhang S. Niche-dependent epistasis within the cancer genome shapes metastatic fitness. bioRxiv [Preprint]. 2026. doi: 10.64898/2026.10.02.756296. [Full text]
  • Aleksandrovic E, Fross SR, Golomb SM, Ma W, Liu X, Zhao Z, Das NM, Reese TC, Borges HM, Tenekeci A, Yu L, Lopez J, Zhao M, Zhong Z, Dean KM, Lea J, Xu L, Stack MS, Zhang S. Tumor-intrinsic IFNγ signaling and niche adaptation drive early colonization in ovarian cancer metastasis. Nature Communications. 2026;17(1):10497. doi: 10.1038/s41467-026-77222-8. PMID: 42834039. [Full text] [PubMed]
  • Chang C, Gan D, Diao L, Wang L, Lacelle C, Hon GC, Li J, Zhao M, Zhang S. Parallel activation and interference CRISPR (PAIR) with sequencing uncovers DNA repair networks guiding precision cell engineering. bioRxiv [Preprint]. 2026. doi: 10.64898/2026.05.08.722799. [Full text]
  • Golomb SM, Guldner IH, Aleksandrovic E, Fross SR, Liu X, Diao L, Liang K, Wu J, Wang Q, Lopez JA, Zhang S. Temporal dynamics of immune cell transcriptomics in brain metastasis progression influenced by gut microbiome dysbiosis. Cell Reports. 2025;44(3):115356. doi: 10.1016/j.celrep.2025.115356. [Full text]
  • Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 2023;14(1):2109. doi: 10.1038/s41467-023-37727-y. [Full text]
  • Bahcecioglu G, Yue X, Howe E, Guldner I, Stack MS, Nakshatri H, Zhang S, Zorlutuna P. Aged breast extracellular matrix drives mammary epithelial cells to an invasive and cancer-like phenotype. Advanced Science. 2021;8(22):2100128. doi: 10.1002/advs.202100128. [Full text]
  • Guldner IH, Golomb SM, Wang Q, Wang E, Zhang S. Isolation of mouse brain-infiltrating leukocytes for single cell profiling of epitopes and transcriptomes. STAR Protocols. 2021;2(2):100537. doi: 10.1016/j.xpro.2021.100537. [Full text]
  • Xu C, Sun S, Johnson T, Qi R, Zhang S, Zhang J, Yang K. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Reports. 2021;35(11):109235. doi: 10.1016/j.celrep.2021.109235. [Full text]
  • Zhang Y, Guldner IH, Nichols EL, Benirschke D, Smith CJ, Zhang S, Howard SS. Instant FLIM enables 4D in vivo lifetime imaging of intact and injured zebrafish and mouse brains. Optica. 2021;8(6):885–897. doi: 10.1364/optica.426870. [Full text]
  • Golomb SM, Guldner IH, Zhao A, Wang Q, Palakurthi B, Aleksandrovic EA, Lopez JA, Lee SW, Yang K, Zhang S. Multi-modal single-cell analysis reveals brain immune landscape plasticity during aging and gut microbiota dysbiosis. Cell Reports. 2020;33(9):108438. doi: 10.1016/j.celrep.2020.108438. [Full text]
  • Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, Brunory A, Howe EN, Zhang Y, Palakurthi B, Barron M, Gao H, Xuei X, Liu Y, Li J, Chen DZ, Landreth GE, Zhang S. CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10. Cell. 2020;183(5):1234–1248.e25. doi: 10.1016/j.cell.2020.09.064. [Full text] [PDF]
  • Wang S, Raybuck A, Shiuan E, Cho SH, Wang Q, Brantley-Sieders DM, Edwards D, Allaman MM, Nathan J, Wilson KT, DeNardo D, Zhang S, Cook R, Boothby M, Chen J. Selective inhibition of mTORC1 in tumor vessels increases antitumor immunity. JCI Insight. 2020;5(15):e139237. doi: 10.1172/jci.insight.139237. [Full text]
  • Howe EN, Burnette MD, Justice ME, Schnepp PM, Hedrick V, Clancy JW, Guldner IH, Lamere AT, Li J, Aryal UK, D'Souza-Schorey C, Zartman JJ, Zhang S. Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth. Nature Communications. 2020;11(1):3017. doi: 10.1038/s41467-020-16832-2. [Full text]
  • Wang Q, Guldner IH, Golomb SM, Sun L, Harris JA, Lu X, Zhang S. Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Nature Communications. 2019;10(1):3817. doi: 10.1038/s41467-019-11729-1. [Full text] [Preprint] [News]
  • Rodriguez KX, Howe EN, Bacher EP, Burnette M, Meloche JL, Meisel J, Schnepp P, Tan X, Chang M, Zartman J*, Zhang S*, Ashfeld BL*. Combined scaffold evaluation and systems-level transcriptome-based analysis for accelerated lead optimization reveals ribosomal targeting spirooxindole cyclopropanes. ChemMedChem. 2019;14(18):1653–1661. doi: 10.1002/cmdc.201900266. [Full text] *Corresponding authors.
  • Ni Y, Schmidt KR, Werner BA, Koenig JK, Guldner IH, Schnepp PM, Tan X, Jiang L, Host M, Sun L, Howe EN, Wu J, Littlepage LE, Nakshatri H, Zhang S. Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer. Nature Communications. 2019;10(1):2860. doi: 10.1038/s41467-019-10743-7. [Full text]
  • Zhang Y, Nichols EL, Zellmer AM, Guldner IH, Kankel C, Zhang S, Howard SS, Smith CJ. Generating intravital super-resolution movies with conventional microscopy reveals actin dynamics that construct pioneer axons. Development. 2019;146(5):dev171512. doi: 10.1242/dev.171512. [Full text]
  • Yue X, Nguyen TD, Zellmer V, Zhang S, Zorlutuna P. Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions. Biomaterials. 2018;170:37–48. doi: 10.1016/j.biomaterials.2018.04.001. [Full text]
  • Barron M, Zhang S, Li J. A sparse differential clustering algorithm for tracing cell type changes via single-cell RNA-sequencing data. Nucleic Acids Research. 2018;46(3):e14. doi: 10.1093/nar/gkx1113. [Full text]
  • Zellmer VR, Schnepp PM, Fracci SL, Tan X, Howe EN, Zhang S. Tumor-induced stromal STAT1 accelerates breast cancer via deregulating tissue homeostasis. Molecular Cancer Research. 2017;15(5):585–597. doi: 10.1158/1541-7786.mcr-16-0312. [Full text]
  • Schnepp PM, Lee DD, Guldner IH, O'Tighearnaigh TK, Howe EN, Palakurthi B, Eckert KE, Toni TA, Ashfeld BL, Zhang S. GAD1 upregulation programs aggressive features of cancer cell metabolism in the brain metastatic microenvironment. Cancer Research. 2017;77(11):2844–2856. doi: 10.1158/0008-5472.can-16-2289. [Full text]
  • Guldner IH, Yang L, Cowdrick KR, Wang Q, Alvarez Barrios WV, Zellmer VR, Zhang Y, Host M, Liu F, Chen DZ, Zhang S. An integrative platform for three-dimensional quantitative analysis of spatially heterogeneous metastasis landscapes. Scientific Reports. 2016;6(1):24201. doi: 10.1038/srep24201. [Full text]
  • Zhang L*, Zhang S*, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100–104. doi: 10.1038/nature15376. [Full text] *Co-first authors.
  • Zhang S, Huang WC, Zhang L, Zhang C, Lowery FJ, Ding Z, Guo H, Wang H, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D. Src family kinases as novel therapeutic targets to treat breast cancer brain metastases. Cancer Research. 2013;73(18):5764–5774. doi: 10.1158/0008-5472.can-12-1803. [Full text]
  • Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, Xiong Y, Tseng LM, Li SH, Ding Z, Sahin AA, Esteva FJ, Hortobagyi GN, Yu D. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nature Medicine. 2011;17(4):461–469. doi: 10.1038/nm.2309. [Full text]
  • Zhang S, Yu D. PI(3)king apart PTEN’s role in cancer. Clinical Cancer Research. 2010;16(17):4325–4330. doi: 10.1158/1078-0432.ccr-09-2990. [Full text]

Check out the complete "List of Published Work" here.